Men Health

Polish researchers have developed a new molecule that selectively reduces bowel cancer tumors in preliminary tests. The compound was chosen from more than 200 synthesized substances and initially tested against…

Aprocitentan (Tryvio; Idorsia Pharmaceuticals), an endothelin receptor antagonist, can safely reduce blood pressure in patients with chronic kidney disease (CKD) and resistant hypertension, according to a post hoc analysis of…

Insilico Medicine has partnered with TaiGen Biotechnology to exclusively license its AI-designed drug ISM4808 for treating chronic kidney disease (CKD)-related anaemia in Greater China. The agreement grants TaiGen and its…

Recent advances in liquid biopsy technology are transforming cancer diagnosis and treatment. One of the most promising developments is the use of circulating tumor DNA (ctDNA) to guide therapy in…

In a recent interview with Urology Times®, Dr. Sia Daneshmand described the KEYNOTE-905 trial as “game-changing” for bladder cancer treatment. The study evaluated the combination of enfortumab vedotin and pembrolizumab,…

Prof. Nuhu Dakum, President of the Association of Urological Surgeons of Nigeria (NAUS), has raised concerns over a rising number of bladder and testicular cancer cases in the country. He…

Aytu BioPharma (NASDAQ: AYTU) has launched EXXUA, its newly FDA-approved treatment for major depressive disorder (MDD), in the United States. EXXUA is the first and only 5HT1a agonist approved specifically…

Losing hair can deeply affect confidence. For many, noticing thinning strands in the shower or a receding hairline in the mirror is a harsh reminder of aging. Increasingly, people are…

Colon cancer rates among young adults in the U.S. are increasing, raising alarms across the medical community. Experts emphasize that fiber-rich diets could be one of the most effective ways…

A new global analysis reveals that more than three-quarters of the world’s population is falling short of essential omega-3 intake, a gap that may elevate the risk of heart disease,…

A new systematic review and meta-analysis published in BMC Public Health links e-cigarette use to an increased risk of heart attack, particularly among former smokers. The study combined data from…

Updated results from a phase 2 trial (NCT05801939) show promising outcomes for cevostamab as a consolidation therapy following BCMA CAR T-cell treatment in patients with multiple myeloma. Among 27 treated…

A new study from the Mayo Clinic, published in the New England Journal of Medicine, suggests that an off-the-shelf, dual-antibody therapy can deliver deep and durable responses in extramedullary multiple…

UK researchers have identified a link between a common childhood virus and bladder cancer later in life, suggesting early intervention could help prevent the disease. The study, led by the…

Two elderly patients with advanced hepatocellular carcinoma (HCC) experienced complete tumor regression after daily use of THC-dominant cannabis oils, according to a recent report published in the Journal of Cannabis…

December is a month many eagerly await, with year-end holidays and festive celebrations for Christmas and New Year. But amid the cheer, health experts warn that these festivities can trigger…

Men over 50 with a history of cannabis use are no more likely to develop prostate cancer than those who have never used the drug, according to a study published…

Daily imaging during prostate cancer radiotherapy could help doctors adjust treatment and reduce side effects, according to new research. A team at the University of Edinburgh used artificial intelligence to…

Sudden weather fluctuations across coastal Karnataka—ranging from intermittent rains and intense heat to chilly mornings—have triggered a rise in health problems. Cases of viral fever, asthma, and skin ailments have…

Better control of metabolic factors could significantly reduce the risk of psoriatic arthritis in patients with psoriasis, according to a new retrospective study. Researchers analyzed data from a large U.S.…